To find candidates with high antimicrobial and low hemolytic activities, many gramicidin S (GS) analogs of various ring sizes have been designed and synthesized. However, syntheses of antimicrobially active analogues of GS having a disordered symmetry structure from C 2 have almost never been reported, because the stable, amphiphilic b b-sheet structure of GS with C 2 symmetry is considered essential for its strong antibacterial activity. In the present studies, novel thirteen cycloundecapeptides 1-13 related to GS were synthesized and examined. Among them, cyclo(-Va1
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In view of widespread antibiotic resistance that has become a serious threat to public health, 1) amphiphilic antibiotics are attractive targets for drug discovery. Gramicidin S (GS), cyclo(-Val [2] [3] [4] is a potent amphiphilic antibiotic isolated from Bacillus brevis. Its secondary structure has been established as an antiparallel b-sheet conformation with C 2 symmetry and amphiphilicity linked by two type IIЈ b-turns around two D-Phe-Pro sequences. 5, 6) It has been proposed that the principal modes of antibiotic actions result from an interaction of GS with the cell membrane of the target microorganisms. GS then adopts an antiparallel b-sheet conformation with C 2 symmetry and amphiphilicity, which disrupts the cell membrane. 3, 4, 7) So far, no resistance has been found toward the antibiotic, presumably because such resistance would require a significant alteration of the lipid composition of the cell membrane. 8) However, GS has high hemolytic activity, preventing its direct use in combating microbial resistance. 9) To find candidates with high antimicrobial and low hemolytic activities, many GS analogs of various ring sizes have been designed and synthesized. 3, 4, 10, 11) However, syntheses of antimicrobially active analogues of GS having a disordered symmetry from C 2 have almost never been reported, because the stable, amphiphilic b-sheet structure of GS with C 2 symmetry is considered essential for its strong antibacterial activity. 3, 4, [10] [11] [12] [13] [14] Recently, we designed and synthesized five antimicrobially active cycloundecapeptides related to GS, cyclo(-Val 6 sequence with a cis D-Phe-Pro peptide bond. In addition, the structural modifications at position 4 are beneficial to identification of novel antibiotic candidates without hemolytic activity. 15) In the present studies, we performed a systematic approach to identify the structural determinants of the antibiotic and hemolytic properties of cycloundecapeptides ( Fig. 1 ) related to GS that induced dissociation of the two closely associated properties.
Experimental
General Melting points were measured on Mel-Temp II melting point apparatus (Laboratory Devices, MA, U.S.A.) and are uncorrected. Unless otherwise noted, all materials were obtained from commercial supplies and used without further purification. Low-resolution mass spectra (LR-MS) were obtained by using fast-atom bombardment (FAB) mass spectrometry on a JEOL600H mass spectrometer (JEOL Ltd., Tokyo, Japan). Syntheses of 4 and 9 were reported in our previous paper. 15) Preparation of GS Analogues 1-13 The syntheses of cycloundecapeptides 1-13 related to GS were performed as shown in Chart 1. The protected linear precursors were prepared by using t-butoxycarbonyl (Boc)-solid phase peptide synthesis (SPS) on oxime resin (loading of oxime group: 0.35 mmol/g resins). [16] [17] [18] Leu residue as a C-terminal amino acid residue was used based on the propensity of the biosynthetic precursor of GS, tyrocidin (TA) and gratisin (GR) to form a conformation highly favorable for head-tail cyclization. 3, 4) The formations of the cyclic peptides by the cyclization-cleavage of the linear precursors on oxime resin were performed in 1,4-dioxane with 2 eq of triethylamine and acetic acid for 1 d at room temperature. All the masking groups of 1-11 and 13 were removed by 25% HBr in acetic acid. The masking groups of the protected precursor of 12 were removed by hydrogenolysis. The cyclic products obtained were purified by means of sephadex LH-20 column chromatography, followed by recrystalization. The purity and identity assessment of the products were confirmed by TLC, HPLC, elemental analysis and FAB mass spectrometry before determination of the biological activities.
Circular Dichroism(CD) Spectra of 1-13 The CD spectra were obtained by use of a JASCO spectra-polarimeter; model J-820 (JASCO Ltd., Tokyo, Japan), using a 0.5-mm quartz cell at room temperature. The CD spectroscopy of 1-13 was carried out with a methanol solution at a concentration of 1.1-1.5ϫ10 and Escherichia coli NBRC l2734 were grown overnight at 37°C on nutrient agar medium and harvested in sterile saline. Densities of bacterial suspensions were determined at 600 nm, using a standard curve relating absorbance to the number of colony forming units (CFU).
Novel Cycloundecapeptides Related to Gramicidin S with Both High Antibiotic Activity and Low Hemolytic Activity
Minimum inhibitory concentrations (MICs) of the synthetic peptides against several bacterial strains were assayed by the microplate dilution method as follows: 100 ml of serial dilution of the synthetic peptide was added to a mixture of 10 ml of bacterial suspension (approximately 10 6 CFU/ml) and 90 ml of Mueller-Hinton broth (Difco Laboratories, NJ, U.S.A.) in each well of a flat-bottomed microplate (Corning Laboratory Sciences Company, NY, U.S.A.). The highest peptide concentration tested was 100 mg/ml. The plates were then incubated overnight at 37°C for MIC evaluation. MIC was expressed as the lowest final concentration (mg/ml) at which no growth was observed. The experiments were performed 7-10 times for each peptide and we obtained results within the same limits of error for each peptide.
Determination of Hemolytic Activity of 1-13 The hemolytic activity of the peptide was determined using sheep red blood cells (RBCs). Freshly collected sheep blood in Alsever's solution (preserved blood) was purchased from Nippon Bio-Test Laboratories Inc. (Tokyo, Japan), and used as the source of the RBCs. The RBCs were isolated from preserved blood by centrifugation at 3000 rpm for 5 min at 4°C and then washed three times with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-NaOH buffered saline (HBS; 150 mM NaCl/5 mM HEPES-NaOH pH 7.4) just prior to the assay. The cyclic peptides were dissolved in water or dimethyl sulfoxide (DMSO) to produce 1 mM cyclic peptide stock solution and stored at Ϫ20°C. Then, each concentration of cyclic peptide was prepared by dilution of the cyclic peptide stock solution in HBS.
To each micro tube, 200 ml of erythrocytes (1% hematocrit in HBS) and 100 ml of each concentration of cyclic peptide was added. The micro tubes were incubated at 37°C for 30 min and centrifuged for 5 min at 3000 rpm and 4°C. The supernatant of each micro tube was transferred to a polystyrene microtiter plate, and the absorbance was measured at 540 nm by a microtiter plate reader. HBS (no peptide) and triton X-100 (added 2 ml of 10% triton X-100) were used as references. The hemolytic activity was calculated as follows: {Abs peptideϪAbs HBS}/{Abs triton X-100ϪAbs HBS}ϫ100. The experiments were carried out three times for each peptide.
Results and Discussion
First, cycloundecapeptides 1-5 ( Fig. 1) having one added Ala residue between two constituent amino acid residues of GS were examined in order to find novel antibiotic candidates with high antimicrobial and low hemolytic activities.
The results are summarized in Table 1 and Fig. 2 .
Peptides 1-5 showed the high antibacterial activities against all Gram-positive bacteria tested. Among them, the activities of 4 were the same as that of GS. The results indicated that perhaps the b-sheet structure with C 2 symmetry was not necessary for the strong antibiotic activity of GS analogues. However, 1-5 showed weak or no activities toward Gram-negative bacteria tested. Thus, it is interesting to note that the introduction of an Ala residue between two constituent amino acid residues of GS shows almost no influence for exhibiting the antibiotic activity against Gram-positive bacteria. Peptides 1, 2 and 3 with one added Ala residue at positions 1, 2 and 3 showed little hemolytic activity. The activity of 4 with one added Ala residue at position 4 was 52% of GS at 100 mM. On the other hand, the hemolytic activity of 5 with one added Ala residue at position 5 was higher than that of GS. The results suggested that the introduction of an Ala residue between two constituent amino acid residues of GS largely affects the interaction against the eukaryotic membrane.
Recently, we reported in synthetic studies of GR (cyclododecapeptide antibiotic), cyclo(-Val . 19, 20) The results suggested that the modifications of Ala residues of 1-5 with cationic amino acid residue are likely to improve the antibacterial and hemolytic activity of cycloundecapeptides 1-5. Next, 6-10 ( Fig. 1) having one added Lys residue between two constituent amino acid residues of GS were examined, in order to find cycloundecapeptides with high antibiotic activities against both Gram-positive and Gram-negative organisms, and low hemolytic activity. The antibiotic activities of 6-10 and GS are summarized in Table 1 and Fig. 3 .
Peptides 6-10 showed the same level of antimicrobial activity as 1-5 against all Gram-positive microorganisms tested. The activities of 6-10 increased compared with that of 1-5 against Gram-negative bacteria tested. Among them, 10 with Lys residue at positions 5 showed two and four times higher activities of GS toward Pseudomonas aeruginosa NBRC3080 and Escherichia coli NBRC12734, respectively. However, the hemolytic activity against sheep erythrocytes of 10 was 86% at 100 mM. The results indicate that the replacement of the Ala residue of 5 with the Lys residue considerably increased the interaction with the Gram-negative bacterial membrane, while it slightly decreased the interaction with mammalian cells.
In order to investigate the role of the added cationic side chain of Lys residue of 10 for exhibiting the antibiotic and hemolytic activity, cycloundecapeptides 11-13, which have one added amino acid residue with the various cationic side chains at position 5, were synthesized. Peptide 13, which has four NH 2 groups, was synthesized in order to investigate the influence of the number of cation groups on antibiotic and hemolytic activities. The antibiotic activities of 11-13 and GS are summarized in Table 1 and Fig. 4 .
Peptides 11-13 showed the same level of antimicrobial activity as 10 against all Gram-positive and Gram-negative microorganisms tested. The results indicated that the type and the number of basic side chains of amino acid residues at position 5 do not largely affect the interaction with both Gram-positive and Gram-negative bacterial membranes. On the other hand, the hemolytic activity against sheep erythrocytes of 12 and 13 was higher than that of 10. The hemolytic activity (at 100 mM) of 11 with an Orn residue with a damino group decreased 70% of 10 with Lys residue with an e-amino group. Thus, a significant increase in the therapeutic index was reported when an added Orn residue was introduced between the D-Phe residue and the Pro residue of GS.
Recently, based on NMR studies of GS14, cyclo(-Val-Lys- Leu-Lys-D-Tyr-Pro-Leu-Lys-Val-Lys-Leu-D-Tyr-Pro-) and its analogues with the amphipathic b-sheet conformation, McInnes et al. reported that the structural basis for the emergence of biologically desirable activities (low hemolytic activity coupled with high antimicrobial activity) is the decreased amphipathicity of certain GS14 analogues. 14) In our present study, it is noteworthy to report that the introduction of one added Orn residue between D-Phe residue and Pro residue of GS might decrease the amphipathicity of GS for the emergence of biologically desirable activities.
Next, the CD spectra of 10-13 and GS were measured in methanol (Fig. 5) . CD spectra of 5 and 10-13 were observed to have a curve similar to each other. The CD spectra of 10-13 in the 215-225 nm region showed a pattern similar to that of GS. On the other hand, in the 190-210 nm region, a shoulder at 198 nm and a trough at 205 nm were observed in the spectra of 10-13, while a trough at 207 nm was observed in the spectrum of GS. In addition, CD spectra of 5 and 10-13 showed weaker intensity compared with that of GS. These results suggest that the conformations of 10-13 in methanol are similar to each other, and that the presence of one added amino acid residue at position 5 of 10-13 makes a slight structural change compared with that of GS.
Conclusion
In conclusion, we found that the structural modifications at position 5 of cycloundecapeptides related to GS are beneficial for the identification of novel antibiotic candidates with lower hemolytic activity. Our findings should be helpful in finding drug candidates with high antimicrobial and low hemolytic activities that are capable of combating microbial resistance. Currently, we are investigating the design and synthesis of other antimicrobially active analogues of GS with a disordered symmetry from C 2 on the basis of the present studies, in order to find new types of drug candidates with high antimicrobial and low hemolytic activities.
